NRX Pharmaceuticals, Inc. (NRXP): 8-K filed Aug 7, 2026

Form type

8-K

Filing date

Aug 7, 2026

Accession number

0001437749-26-026428

Filer

NRX Pharmaceuticals, Inc. (CIK 1719406)